NCT07028229

Brief Summary

This is a prospective, interventional study aiming to develop and validate an ultrasound training program for gynecology and obstetrics residents, focused on the staging of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The program consists of theoretical lectures, practical hands-on sessions, and supervised clinical case evaluations over a six-month period. Residents will perform ultrasound examinations independently, which will be compared to those conducted by expert sonographers. The primary objective is to assess the learning curve of each trainee by evaluating diagnostic concordance with expert findings across specific staging parameters.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
6

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 11, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

June 16, 2025

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 19, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

June 19, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

June 11, 2025

Last Update Submit

June 11, 2025

Conditions

Keywords

Resident TrainingLearning CurveGynecologic OncologyTransvaginal Ultrasound

Outcome Measures

Primary Outcomes (1)

  • Agreement Rate Between Residents and Experts in Ultrasound-Based Staging of Gynecologic Cancers

    Assessment of the diagnostic concordance between ultrasound staging performed by residents and expert sonographers, measured across defined anatomical and pathological parameters (e.g., lymph node involvement, carcinomatosis, tumor size and spread). Concordance will be quantified as the percentage of agreement per case and per parameter.

    Up to 6 months (from the start to the end of the training program)

Study Arms (1)

Training Group

EXPERIMENTAL

Gynecology and obstetrics residents enrolled in a structured ultrasound training program focused on staging of gynecologic cancers. The program includes theoretical lessons, supervised hands-on sessions, and independent ultrasound assessments compared with expert findings.

Behavioral: Training Group

Interventions

Training GroupBEHAVIORAL

A structured educational and practical training program in gynecologic oncology ultrasound designed for residents. The intervention includes lectures, clinical case discussions, supervised and independent ultrasound examinations, and performance assessments to evaluate learning progression and diagnostic concordance with experts.

Also known as: Ultrasound Training Program for Gynecologic Cancer Staging
Training Group

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsThis study enrolls female patients diagnosed or suspected of having gynecologic cancers (ovarian, endometrial, or cervical cancer) who undergo ultrasound examinations. Medical residents of any gender specializing in gynecology and obstetrics are eligible to participate as trainees in the ultrasound training program.
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least six gynecology residents who will regularly attend the ultrasound center daily, with overlapping shifts.
  • All patients with a diagnosis or suspected diagnosis of gynecological cancer, including ovarian, endometrial, and cervical cancers, will be included in the study and scanned by both residents and experts.
  • Signing of the informed consent by the participants.

You may not qualify if:

  • non-gynecology specialists, with attendance schedules at the center other than daily.
  • Failure to sign the informed consent by the participants.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Roma, 00168, Italy

Location

MeSH Terms

Conditions

Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms

Interventions

Sensitivity Training Groups

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesEndocrine System DiseasesGonadal DisordersUterine NeoplasmsUterine DiseasesUterine Cervical Diseases

Intervention Hierarchy (Ancestors)

Psychotherapy, GroupSocioenvironmental TherapyPsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Antonia Carla Testa

    Fondazione Policlinico Universitario Agostino Gemelli

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 11, 2025

First Posted

June 19, 2025

Study Start

June 16, 2025

Primary Completion

September 30, 2025

Study Completion

December 30, 2025

Last Updated

June 19, 2025

Record last verified: 2025-06

Locations